Peng Cao

Dr. Peng Cao

Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA
+1
orcid

Biography

Dr. Cao’s research focuses on the molecular mechanisms and therapeutic interventions for liver diseases, particularly drug induced liver injury (DILI), metabolic dysfunction associated steatotic liver disease (MASLD/MASH), and alcoholic hepatitis (AH). His work integrates target discovery, mechanistic dissection, and natural product based drug development.

Affiliations

University of Kansas Medical Center

Kansas City, Kansas, USA

Department of Pharmacology, Toxicology and Therapeutics

Huazhong University of Science and Technology

Wuhan, Hubei, China

Department of Pharmacy

Honors and Awards

No honors or awards have been shared yet.

Experience

No experience has been shared yet.